These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35264984)

  • 1. Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder.
    Wu Z; Yu H; Tian Y; Wang Y; He Y; Lan T; Li Y; Bai M; Chen X; Chen Z; Ji P; Zhang H; Jin X; Song J; Cheng K; Xie P
    Front Psychiatry; 2021; 12():810302. PubMed ID: 35264984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder.
    Nie LJ; Liang J; Shan F; Wang BS; Mu YY; Zhou XH; Xia QR
    Front Psychiatry; 2021; 12():671151. PubMed ID: 34658942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity.
    Ho CSH; Tay GWN; Wee HN; Ching J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolites were associated with spatial working memory in major depressive disorder.
    Du Y; Wei J; Yang X; Dou Y; Zhao L; Qi X; Yu X; Guo W; Wang Q; Deng W; Li M; Lin D; Li T; Ma X
    Medicine (Baltimore); 2021 Feb; 100(8):e24581. PubMed ID: 33663067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulations of amino acid metabolism and lipid metabolism in urine of children and adolescents with major depressive disorder: a case-control study.
    Jiang Y; Cai Y; Teng T; Wang X; Yin B; Li X; Yu Y; Liu X; Wang J; Wu H; He Y; Zhu ZJ; Zhou X
    Psychopharmacology (Berl); 2024 Aug; 241(8):1691-1703. PubMed ID: 38605232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.
    Zhao X; Feng X; Zhao X; Jiang Y; Li X; Niu J; Meng X; Wu J; Xu G; Hou L; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():659268. PubMed ID: 34149613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breathomics profiling of metabolic pathways affected by major depression: Possibilities and limitations.
    Gbaoui L; Fachet M; Lüno M; Meyer-Lotz G; Frodl T; Hoeschen C
    Front Psychiatry; 2022; 13():1061326. PubMed ID: 36590606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents.
    Jiang Y; Qin M; Teng T; Li X; Yu Y; Wang J; Wu H; He Y; Zhou X; Xie P
    Front Psychiatry; 2022; 13():929207. PubMed ID: 35911235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder.
    Bai S; Xie J; Bai H; Tian T; Zou T; Chen JJ
    J Inflamm Res; 2021; 14():3755-3766. PubMed ID: 34393496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis.
    You Z; Wang C; Lan X; Li W; Shang D; Zhang F; Ye Y; Liu H; Zhou Y; Ning Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110849. PubMed ID: 37659714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DI/LC-MS/MS-Based Metabolome Analysis of Plasma Reveals the Effects of Sequestering Agents on the Metabolic Status of Dairy Cows Challenged with Aflatoxin B
    Ogunade I; Jiang Y; Pech Cervantes A
    Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31779109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder.
    Du Y; Wei J; Zhang Z; Yang X; Wang M; Wang Y; Qi X; Zhao L; Tian Y; Guo W; Wang Q; Deng W; Li M; Lin D; Li T; Ma X
    Front Psychiatry; 2021; 12():644555. PubMed ID: 34646171
    [No Abstract]   [Full Text] [Related]  

  • 18. Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry.
    Homorogan C; Nitusca D; Enatescu V; Schubart P; Moraru C; Socaciu C; Marian C
    Metabolites; 2021 Jul; 11(7):. PubMed ID: 34357360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.
    Ding X; Yang S; Li W; Liu Y; Li Z; Zhang Y; Li L; Liu S
    PLoS One; 2014; 9(5):e97479. PubMed ID: 24870353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
    Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
    J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.